semaglutide causes gastroparesis Stomach paralysis is the rare Ozempic risk worth watching Your patient took semaglutide this

On July 1, ReShape Medical announced that it has submitted a premarket approval application to the FDA for its ReShape Integrated Dual Balloon System aimed at people with a body mass index of 30-40

Who do you think will dominate this space

Research has shown that adults with obesity taking semaglutide lost an average of 15% of their body weight over 68 weeks, highlighting its effectiveness as a weight management tool

"That's a navigation aid or a wayfinder for consumers who are currently on GLP-1s," Connolly said

+ - BPC-157 shows promise in animal studies with few serious side effects, but human data is limited, with potential risks including injection site issues (pain, swelling, infection) and theoretical concerns like pathological angiogenesis (tumor growth) or hormonal imbalance

In addition, foods that are rich in fat tend to increase negative gastrointestinal side effects